Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

01-12-2020 | Silicone | Case report

Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report

Authors: Christina Stathopoulos, Jessica Sergenti, Marie-Claire Gaillard, Francis L. Munier, Alejandra Daruich

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Tractional retinal detachment with or without secondary tear is a rare complication reported in less than 0.5% of in eyes treated for retinoblastoma. Pars plana vitrectomy (PPV) in eyes with history of retinoblastoma has been associated with a significant risk for recurrence, extraocular spread, and systemic metastases. We report here the successful management by PPV under melphalan irrigation of 2 children presenting with tractional retinal detachment after retinoblastoma therapy and scleral buckle surgery.

Case presentation

A 7-year-old girl with a history of bilateral retinoblastoma (group D) presented with light perception best-corrected visual acuity (BCVA) and tractional retinal detachment (RD) in her left eye, 3 years after the last intra-arterial chemotherapy (IAC) injection. Moreover, she had history of left eye rhegmatogenous RD treated by scleral buckle 1 month after the last IAC and cataract surgery 12 months later. PPV associated with retinectomy, laser photocoagulation and silicone oil tamponade was performed. Silicone oil was removed 4 months later. Fifteen months after PPV, BCVA had increased to 20/32 without recurrence of RD and no evidence of tumor activity. A 7-year-old boy with a history of unilateral retinoblastoma (group D) in his left eye presented with rhegmatogenous RD 21 months after the last treatment for retinoblastoma. Scleral buckle surgery was performed, but 3 weeks later the patient presented with tractional RD associated with proliferative vitreo-retinopathy. BCVA was counting fingers. PPV associated with membrane peel, laser photocoagulation and silicone oil tamponade was performed. Silicone oil was removed after 5 months followed by cataract surgery 5 months later. Twenty months after PPV, BCVA was 20/20 and there was no sign of tumor recurrence.

Conclusions

PPV under melphalan irrigation, with retinectomy, if necessary, and silicone oil tamponade, allows anatomical and functional improvement in eyes with history of retinoblastoma and scleral buckling developing tractional RD.
Literature
1.
go back to reference Tawansy KA, Samuel MA, Shammas M, Murphree AL. Vitreoretinal complications of retinoblastoma treatment. Retina Phila Pa. 2006;26(7 Suppl):S47–52.CrossRef Tawansy KA, Samuel MA, Shammas M, Murphree AL. Vitreoretinal complications of retinoblastoma treatment. Retina Phila Pa. 2006;26(7 Suppl):S47–52.CrossRef
2.
go back to reference Baumal CR, Shields CL, Shields JA, Tasman WS. Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma. Ophthalmology. 1998;105:2134–9.CrossRef Baumal CR, Shields CL, Shields JA, Tasman WS. Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma. Ophthalmology. 1998;105:2134–9.CrossRef
3.
go back to reference Shields CL, Say EAT, Pefkianaki M, Regillo CD, Caywood EH, Jabbour PM, et al. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: the 2016 founders award lecture. Retina Phila Pa. 2017;37:1441–50.CrossRef Shields CL, Say EAT, Pefkianaki M, Regillo CD, Caywood EH, Jabbour PM, et al. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: the 2016 founders award lecture. Retina Phila Pa. 2017;37:1441–50.CrossRef
4.
go back to reference Elaraoud I, Ch’ng S, Karl D, Kalogeropoulos D, Chavan R, Sharma A. Management of retinal detachment in retinoblastoma with globe conserving treatment. J Curr Ophthalmol. 2019;31:43–8.CrossRef Elaraoud I, Ch’ng S, Karl D, Kalogeropoulos D, Chavan R, Sharma A. Management of retinal detachment in retinoblastoma with globe conserving treatment. J Curr Ophthalmol. 2019;31:43–8.CrossRef
5.
go back to reference Bovey EH, Fernandez-Ragaz A, Héon E, Balmer A, Munier FL. Rhegmatogenous retinal detachment after treatment of retinoblastoma. Ophthalmic Genet. 1999;20:141–51.CrossRef Bovey EH, Fernandez-Ragaz A, Héon E, Balmer A, Munier FL. Rhegmatogenous retinal detachment after treatment of retinoblastoma. Ophthalmic Genet. 1999;20:141–51.CrossRef
6.
go back to reference Yousef YA, Manna M, Khalil MB, Nawaiseh I. Surgical repair of rhegmatogenous retinal detachment in eyes harboring active retinoblastoma. Ophthalmic Genet. 2016;37:314–7.CrossRef Yousef YA, Manna M, Khalil MB, Nawaiseh I. Surgical repair of rhegmatogenous retinal detachment in eyes harboring active retinoblastoma. Ophthalmic Genet. 2016;37:314–7.CrossRef
7.
go back to reference Mullaney PB, Abboud EB, Al-Mesfer SA. Retinal detachment associated with type III retinoblastoma regression after cryotherapy and external-beam radiotherapy. Am J Ophthalmol. 1997;123:140–2.CrossRef Mullaney PB, Abboud EB, Al-Mesfer SA. Retinal detachment associated with type III retinoblastoma regression after cryotherapy and external-beam radiotherapy. Am J Ophthalmol. 1997;123:140–2.CrossRef
8.
go back to reference Hwang CS, Mendoza PR, Wells JR, Grossniklaus HE, Hubbard GB. Proliferative Vitreoretinopathy in treated retinoblastoma. Ophthalmol Retina. 2017;1:165–72.CrossRef Hwang CS, Mendoza PR, Wells JR, Grossniklaus HE, Hubbard GB. Proliferative Vitreoretinopathy in treated retinoblastoma. Ophthalmol Retina. 2017;1:165–72.CrossRef
9.
go back to reference Honavar SG, Shields CL, Shields JA, Demirci H, Naduvilath TJ. Intraocular surgery after treatment of retinoblastoma. Arch Ophthalmol 1960. 2001;119:1613–1621.CrossRef Honavar SG, Shields CL, Shields JA, Demirci H, Naduvilath TJ. Intraocular surgery after treatment of retinoblastoma. Arch Ophthalmol 1960. 2001;119:1613–1621.CrossRef
10.
go back to reference Warden SM, Mukai S. Pars plana vitrectomy in eyes treated for retinoblastoma. Retina Phila Pa. 2006;26(7 Suppl):S53–6.CrossRef Warden SM, Mukai S. Pars plana vitrectomy in eyes treated for retinoblastoma. Retina Phila Pa. 2006;26(7 Suppl):S53–6.CrossRef
11.
go back to reference Madreperla SA, Hungerford JL, Cooling RJ, Sullivan P, Gregor Z. Repair of late retinal detachment after successful treatment of retinoblastoma. Retina Phila Pa. 2000;20:28–32.CrossRef Madreperla SA, Hungerford JL, Cooling RJ, Sullivan P, Gregor Z. Repair of late retinal detachment after successful treatment of retinoblastoma. Retina Phila Pa. 2000;20:28–32.CrossRef
12.
go back to reference Linn MA. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41–53 viii.CrossRef Linn MA. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41–53 viii.CrossRef
13.
go back to reference Anagnoste SR, Scott IU, Murray TG, Kramer D, Toledano S. Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy. Am J Ophthalmol. 2000;129:817–9.CrossRef Anagnoste SR, Scott IU, Murray TG, Kramer D, Toledano S. Rhegmatogenous retinal detachment in retinoblastoma patients undergoing chemoreduction and cryotherapy. Am J Ophthalmol. 2000;129:817–9.CrossRef
14.
go back to reference Saumya Pal S, Gopal L, Khetan V, Nagpal A, Sharma T. Rhegmatogenous retinal detachment following treatment for retinoblastoma. J Pediatr Ophthalmol Strabismus. 2010;47:349–55.CrossRef Saumya Pal S, Gopal L, Khetan V, Nagpal A, Sharma T. Rhegmatogenous retinal detachment following treatment for retinoblastoma. J Pediatr Ophthalmol Strabismus. 2010;47:349–55.CrossRef
15.
go back to reference Tanaka M, Yokoi T, Ito M, Kobayashi Y, Noda E, Matsuoka K, et al. Three cases of rhegmatogenous retinal detachment associated with regressed retinoblastoma after conservative tumor therapy. Retin Cases Brief Rep. 2014;8:223–6.CrossRef Tanaka M, Yokoi T, Ito M, Kobayashi Y, Noda E, Matsuoka K, et al. Three cases of rhegmatogenous retinal detachment associated with regressed retinoblastoma after conservative tumor therapy. Retin Cases Brief Rep. 2014;8:223–6.CrossRef
16.
go back to reference Shimoda Y, Hamano R, Ishihara K, Shimoda N, Hagimura N, Akiyama H, et al. Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2008;246:501–8.CrossRef Shimoda Y, Hamano R, Ishihara K, Shimoda N, Hagimura N, Akiyama H, et al. Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2008;246:501–8.CrossRef
17.
go back to reference Yarovoy AA, Ushakova TL, Gorshkov IM, Polyakov VG, Golubeva OV, Gorovtsova OV, et al. Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma. Eur J Ophthalmol. 2015;26:e17–9.CrossRef Yarovoy AA, Ushakova TL, Gorshkov IM, Polyakov VG, Golubeva OV, Gorovtsova OV, et al. Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma. Eur J Ophthalmol. 2015;26:e17–9.CrossRef
Metadata
Title
Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report
Authors
Christina Stathopoulos
Jessica Sergenti
Marie-Claire Gaillard
Francis L. Munier
Alejandra Daruich
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-1315-7

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue